(Q36903108)

17 August 2017

1 reference

title

Peroxisome proliferator-activated receptors: new players in the field of reproduction (English)

1 reference

17 August 2017

5

Klaus Friese

1 reference

17 August 2017

Bettina Toth

1

1 reference

17 August 2017

Daniela Hornung

2

1 reference

17 August 2017

Christoph Scholz

3

1 reference

17 August 2017

Schima Djalali

4

1 reference

17 August 2017

Udo Jeschke

6

1 reference

17 August 2017

publication date

1 September 2007

1 reference

American Journal of Reproductive Immunology

17 August 2017

published in

1 reference

17 August 2017

volume

58

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

289-310

1 reference

The many faces of PPARgamma

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

PPAR gamma and human metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Impact of genetic variation of PPARgamma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Hepatotoxicity with thiazolidinediones: is it a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The pleiotropic function of PPAR gamma in the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Endometriosis: treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Regulated on activation, normal T-cell-expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Advances in the management of endometriosis: an update for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Retinoid X receptors are essential for early mouse development and placentogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Intrauterine infection and preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Cytokines, prostaglandins and parturition--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated k

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Oxidative stress in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2007.00514.X

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1111/J.1600-0897.2007.00514.X

15 July 2023

Identifiers

DOI

1 reference

17 August 2017

1 reference